Loading...
 


Speakers and panelists


Guest Speakers


Réjean Hébert, ministre de la Santé et des Services sociaux et ministre Responsable des Aînés

François Meyer, Advisor to the CEO of France HAS, International Relations


Panelists


Reiner Banken, Advisor to the CEO of INESSS

Gaétan Barrette, President, Fédération des médecins spécialistes du Québec

Alain Boisvert, Vice-President, Market Access and Public Affairs, Bristol-Myers Squibb
Canada

Luc Castonguay, Assistant-Deputy Minister, Direction générale de la planification, de la performance et de la qualité, Ministère de la Santé et des Services sociaux du Québec

Diane Côté, President and Chief Executive Officer, Quebec Research and Innovation Consortium in Medical Technologies, MEDTEQ

Véronique Déry, Chief Scientific Advisor, INESSS

Juan Roberto Iglesias, President and Chief Executive Officer of INESSS

Louise Lavergne, President and Chief Executive Officer, Institut de réadaptation en déficience physique de Québec

Paul Lirette, President, GlaxoSmithKline Canada

Teresa Mattarelli, Vice-President and General Manager, Covidien Canada

Marc Rhainds, Medical and Scientific Manager of HTA activities, CHU de Québec


Facilitators


Stéphane Ahern, Internist-intensivist, Maisonneuve-Rosemont Hospital and Chair of INESSS Comité scientifique permanent de l'évaluation des médicaments aux fins d'inscription (CSEMI)

François Bastien, General Manager, Health, Public and Parapublic markets,Telus

Christian Bellemare, Coordinator, Health Technology Assessment Unit,CHUS Hôtel-Dieu

Sylvie Bouchard, Scientific Director, Follow-up and Optimal Use, INESSS

Dan Cooper, Principal Scientific Advisor- Pharmacoeconomics, INESSS

Pierre Dagenais, Director, Directorate of Quality and Method Support, INESSS

Kim Furlong, Director, Government Affairs, Amgen
Benoit Larose, Vice President, MEDEC, Québec

Michelle Laflamme, President and Chief Executive Officer, Émovi

Luigi Lepanto, Director, Health Technology Assessment Unit, CHUM

France Mignault, Director, Government Affairs, Québec, Janssen

Marc Osborne, Director, Government Relations and Health Policy Oncology Division, Hoffman-LaRoche

Gilles Pineau, Coordinator, Oncology Assessment Unit, INESSS

Sophie Rochon, Senior Manager, Patient Access and Health Policy, Pfizer

Jean Rousseau, Business Unit Director, Covidien

Éric St-Gelais, Conseiller en orientation et coordination de la recherche et de l'innovation, MSSS